Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v2-FR
Language English French
Date Updated 2021-09-21 2021-09-03
Drug Identification Number 02420872 02420872
Brand name ABILIFY MAINTENA ABILIFY MAINTENA
Common or Proper name Abilify Maintena Abilify Maintena
Company Name OTSUKA PHARMACEUTICAL CO LTD OTSUKA PHARMACEUTICAL CO LTD
Ingredients ARIPIPRAZOLE ARIPIPRAZOLE
Strength(s) 400MG 400MG
Dosage form(s) KIT POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT POWDER FOR SUSPENSION, SUSTAINED-RELEASE
Route of administration INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR
Packaging size kit kit
ATC code N05AX N05AX
ATC description ANTIPSYCHOTICS ANTIPSYCHOTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2021-09-02 2021-09-02
Actual start date 2021-09-15 2021-09-20
Estimated end date Unknown
Actual end date 2021-09-20
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments